Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro

被引:23
作者
Liang, Xinjun [1 ]
Da, Mingxu [2 ]
Zhuang, Zhiqiang [1 ]
Wu, Weiguang [1 ]
Wu, Zhuang [1 ]
Wu, Yanfeng [1 ]
Shen, Huiyong [1 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthopaed, Guangzhou 510120, Guangdong, Peoples R China
[2] Gansu Prov Hosp, Dept Gen Surg, Lanzhou 730000, Peoples R China
关键词
Osteosarcoma; Survivin; Apoptosis; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-SIGNIFICANCE; GROWTH INHIBITION; GENE-THERAPY; CANCER-CELLS; EXPRESSION; OSTEOSARCOMA; ANGIOGENESIS; SUPPRESSION; EXTREMITIES;
D O I
10.1016/j.cellbi.2008.10.013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osteosarcoma is the most frequent primary malignant tumor of the skeleton and occurs mainly in children and adolescent. The prognosis of osteosarcoma is very poor due to its aggressive and no effective treatment. This study is the first to investigate the anti-cancer effects of antisense pEGFP-C1-Survivin on human osteosarcoma cells. It was shown in our results that Survivin blockaded could significantly induce apoptosis and inhibit the invasive of osteosarcoma cells line MG-63. The effects were probably produced by the decreased expression of Survivin induced by antisense pEGFP-C1-Survivin which was examined by RT-PCR and western blotting. All these suggested that Survivin should be very important in the development of osteosarcoma and Survivin blockaded by using antisense pEGFP-C1-Survivin could markedly inhibit the proliferation and invasion of osteosarcoma cells line MG-63, partially reversed their malignant phenotype. Targeting Survivin might be a promising option in the treatment of osteosarcoma. (C) 2008 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 40 条
  • [1] Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer
    Ai, Zhihong
    Yin, Lianhua
    Zhou, Xianrong
    Zhu, Ying
    Zhu, Dongmei
    Yu, Yinhua
    Feng, Youji
    [J]. CANCER, 2006, 107 (04) : 746 - 756
  • [2] A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
    Ambrosini, G
    Adida, C
    Altieri, DC
    [J]. NATURE MEDICINE, 1997, 3 (08) : 917 - 921
  • [3] Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide
    Bacci, G
    Briccoli, A
    Rocca, M
    Ferrari, S
    Donati, D
    Longhi, A
    Bertoni, F
    Bacchini, P
    Giacomini, S
    Forni, C
    Manfrini, M
    Galletti, S
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (07) : 1126 - 1134
  • [4] Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years - Outcome in 34 cases treated with Adriamycin, Cisplatinum and Ifosfamide between 1984 and 1999
    Bacci, Gaetano
    Ferrari, Stefano
    Mercuri, Mario
    Longhi, Alessandra
    Fabbri, Nicola
    Galletti, Stefano
    Forni, Cristiana
    Balladelli, Alba
    Serra, Massimo
    Picci, Piero
    [J]. ACTA ORTHOPAEDICA, 2007, 78 (03) : 377 - 384
  • [5] Survivin expression in Tuberous Sclerosis Complex cells
    Carelli, Stephana
    Lesma, Elena
    Paratore, Simona
    Grande, Vera
    Zadra, Giorgia
    Bosari, Silvano
    Di Giulio, Anna Maria
    Gorio, Alfredo
    [J]. MOLECULAR MEDICINE, 2007, 13 (3-4) : 166 - 177
  • [6] Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells
    Chao, JI
    Kuo, PC
    Hsu, TS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) : 20267 - 20276
  • [7] Cho HJ, 2007, J BIOCHEM MOL BIOL, V40, P1069
  • [8] Treatment of osteosarcoma at first recurrence after contemporary therapy - The Memorial Sloan-Kettering Cancer Center Experience
    Chou, AJ
    Merola, PR
    Wexler, LH
    Gorlick, RG
    Vyas, YM
    Healey, JH
    LaQuaglia, MP
    Huvos, AG
    Meyers, PA
    [J]. CANCER, 2005, 104 (10) : 2214 - 2221
  • [9] Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis
    Cohen, C
    Lohmann, CM
    Cotsonis, G
    Lawson, D
    Santoianni, R
    [J]. MODERN PATHOLOGY, 2003, 16 (06) : 574 - 583
  • [10] Markers of angiogenesis and clinical features in patients with sarcoma
    DuBois, Steven
    Demetri, George
    [J]. CANCER, 2007, 109 (05) : 813 - 819